FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Dividend Details

COMPANY PROFILE

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1288.65117.15 (+10 %)

PREV CLOSE (Rs.) 1171.50

OPEN PRICE (Rs.) 1202.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 29084

TODAY'S LOW / HIGH (Rs.)1202.10 1288.65

52 WK LOW / HIGH (Rs.)890 1577.5

NSE1284.40116.7 (+9.99 %)

PREV CLOSE( Rs. ) 1167.70

OPEN PRICE (Rs.) 1205.00

BID PRICE (QTY) 1284.40 (103055)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 335041

TODAY'S LOW / HIGH(Rs.) 1201.00 1284.40

52 WK LOW / HIGH (Rs.)889 1580

More From Company Profile

Dividend Details

Dividend Date	Record Date	Dividend %	Interim / Final / Dividend

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Filing complaints on SCORESEasy & quick

Register on SCORES portal
Mandatory details for filling complaints on SCORES
Name PAN Address Mobile Number E-Mail ID
Benefits:
Effective communication Speedy redressal of the grievances

https://scores.sebi.gov.in

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22